RATIONAL ADVISORS LLC - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 92 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 13.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
RATIONAL ADVISORS LLC ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$29,000
-97.5%
5,000
-92.2%
0.02%
-96.0%
Q3 2015$1,182,000
-5.1%
64,0000.0%0.48%
+19.5%
Q2 2015$1,245,000
+8.9%
64,000
-1.5%
0.40%
+44.4%
Q1 2015$1,143,000
-12.8%
65,000
-20.7%
0.28%
+6.5%
Q4 2014$1,311,000
-0.6%
82,0000.0%0.26%
+130.1%
Q4 2013$1,319,000
-3.3%
82,0000.0%0.11%
+8.7%
Q3 2013$1,364,000
+65.1%
82,0000.0%0.10%
+50.7%
Q2 2013$826,000
-3.2%
82,0000.0%0.07%
+15.0%
Q1 2013$853,000
+15.9%
82,0000.0%0.06%
+1.7%
Q4 2012$736,000
-18.8%
82,0000.0%0.06%
-15.7%
Q3 2012$906,000
+0.7%
82,0000.0%0.07%
-4.1%
Q2 2012$900,000
+114.3%
82,0000.0%0.07%
+121.2%
Q1 2012$420,000
-4.3%
82,0000.0%0.03%
-13.2%
Q4 2011$439,000
-56.8%
82,000
-50.0%
0.04%
-22.4%
Q3 2011$1,017,000
-8.5%
164,0000.0%0.05%
-5.8%
Q2 2011$1,111,000
+86.7%
164,000
+100.0%
0.05%
+8.3%
Q1 2011$595,000
-6.9%
82,0000.0%0.05%
-14.3%
Q4 2010$639,000
+5.3%
82,0000.0%0.06%
-3.4%
Q1 2010$607,000
+3.8%
82,0000.0%0.06%0.0%
Q4 2009$585,000
+7.1%
82,0000.0%0.06%
+5.5%
Q3 2009$546,000
-50.3%
82,0000.0%0.06%
-58.3%
Q2 2009$1,099,000
+39.6%
82,000
+43.9%
0.13%
+12.8%
Q1 2009$787,00057,0000.12%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,035,709$37,600,0005.29%
GREAT POINT PARTNERS LLC 75,000$1,385,0000.55%
Hood River Capital Management LLC 204,653$3,780,0000.52%
Timpani Capital Management LLC 69,640$1,286,0000.52%
RATIONAL ADVISORS LLC 64,000$1,182,0000.48%
PIPER SANDLER & CO. 22,000$406,0000.43%
PRINCETON CAPITAL MANAGEMENT INC 34,825$643,0000.39%
TFS CAPITAL LLC 101,070$1,867,0000.18%
FALCON POINT CAPITAL, LLC 26,557$491,0000.18%
EAM Investors, LLC 56,694$1,047,0000.17%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders